Robert E. Landry, Director: Cytokinetics CYTK Planned sale · Filed 09/11

Trade details

Type: Planned sale notice
Stock: Cytokinetics CYTK
Person: Robert E. LandryDirector
Planned sale date: 26/09/11
Filed: 26/09/11

$147.2K to be sold

Cytokinetics trades, last 26 weeks

What else happened in Cytokinetics around then

Filed or reported within 30 days of the trade day · 08/12~10/11

Robert E. Landry's recent trades

Robert E. LandryEVP Finance CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$188.2K
223 sh
$188.2K
Filed 23/08/25
Traded 23/08/23
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$200.6K
243 sh
$200.6K
Filed 23/03/29
Traded 23/03/28
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$149.1K
181 sh
$149.1K
Filed 23/03/29
Traded 23/03/28
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$129.5K
157 sh
$129.5K
Filed 23/03/29
Traded 23/03/28
Robert E. LandryEVP Finance CFO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$116.6K
142 sh
$116.6K
Filed 23/03/29
Traded 23/03/28

Robert E. Landry, Director — plans to sell 2,000 sh of Cytokinetics CYTK · $147.2K · around 09/11 · 10b5-1 plan | Whalegun